Reports
.webp)
The joint pain injections market size is projected to grow from USD 6.45 billion in 2026 to USD 11.38 billion by 2034 at a CAGR of 7.36% from 2026 to 2034.
The global pharmaceutical membrane filtration market size was valued at USD 8.88 billion in 2025 and is estimated to reach USD 19.61 billion by 2034, growing at a CAGR of 9.22% during the forecast period.
The global IV and Oral Iron Drugs Market size was valued at USD 8.65 billion in 2025 and is estimated to reach USD 22.86 billion by 2034, growing at a CAGR of 11.43% during the forecast period.
The global renal replacement therapy market size is estimated to reach USD 2.75 billion by 2032, growing at a CAGR of 7.9% from 2024 to 2032.
The immunosuppressants market size was valued at USD 43.01 billion in 2025 and is projected to grow from USD 46.78 billion in 2026 to USD 92.78 billion by 2034 at a CAGR of 8.94% during the forecast period (2026-2034).
The global insulin glargine market size was valued at USD 2.47 billion in 2025 and is estimated to reach USD 4.32 billion by 2034, growing at a CAGR of 6.43% during the forecast period.
The global nuclear imaging equipment market size is valued at USD 7.21 billion in 2025 and is estimated to reach USD 9.52 billion by 2034, growing at a CAGR of 3.18% during the forecast period, according to Straits Research.
The global natural killer (NK) cell therapeutics market size was valued at USD 276.43 million in 2025 and is estimated to reach USD 6,252.74 million by 2034, growing at a CAGR of 41.44% during the forecast period.
The global nucleic acid therapeutics CDMO market size was valued at USD 17.42 billion in 2025 and is estimated to reach USD 57.37 billion by 2034, growing at a CAGR of 14.18% during the forecast period.
The immunoglobulins market size was valued at USD 19.79 billion in 2025 and is projected to grow from USD 21.33 billion in 2026 to USD 38.93 billion by 2034 at a CAGR of 7.81% during the forecast period (2026-2034), as per Straits Research analysis.
The Global Pemphigus Vulgaris Market Size is estimated to reach USD 1119.42 million in 2034, growing at a CAGR of 8.2% during the forecast period (2026–2034).
The global biomarkers market size was valued at USD 101.38 billion in 2025 and is estimated to reach USD 301.64 billion by 2034, growing at a CAGR of 12.88% during the forecast period.
The global cancer immunotherapy drug discovery outsourcing market size is projected to grow from USD 1.98 billion in 2026 to USD 5.58 billion by 2034, registering a CAGR of 13.79% during the forecast period (2026–2034).
The global label-free detection market size is valued at USD 1.89 billion in 2025 and is estimated to reach USD 4.80 billion by 2034, growing at a CAGR of 10.93% during the forecast period.
The cyclosporine market size was valued at USD 2.11 billion in 2025 and is projected to reach USD 3.07 billion by 2034 at a CAGR of 4.28% from 2026 to 2034.
The angina pectoris drugs market size was valued at USD 12.15 billion in 2025 and is projected to reach USD 17.28 billion by 2034 at a CAGR of 4.01% from 2026 to 2034.
The rotavirus vaccines market size was valued at USD 5.58 billion in 2025 and is projected to reach USD 13.17 billion by 2034 at a CAGR of 12.02% from 2026 to 2034.
The global cerebral palsy treatment market size was valued at USD 3.58 billion in 2025 and is estimated to reach USD 4.74 billion by 2034, growing at a CAGR of 3.19% during the forecast period.
The pediatric vaccines market size was valued at USD 48.46 billion in 2025 and is projected to reach USD 69.67 billion by 2034 at a CAGR of 4.14% from 2026 to 2034.
The global animal vaccine market size was valued at USD 12 billion in 2025 and is estimated to reach USD 21 billion by 2034, growing at a CAGR of 6% during the forecast period.
